Notice: This company has been marked as potentially delisted and may not be actively trading. (BIOA) (BIOA) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsCompetitorsHeadlinesInsider TradesOwnershipTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CHMP issues positive recommendation for approval of lecanemab in the EUNovember 14, 2024 | finance.yahoo.comEisai updates Leqembi® outlook for fiscal year 2024 (April 2024 - March 2025). Sales now expected to reach JPY 42.5 billionNovember 8, 2024 | finance.yahoo.comBioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 7, 2024 | globenewswire.comBrainTransporter™ dramatically improves antibody delivery to the brainNovember 7, 2024 | uk.finance.yahoo.comInvitation to presentation of BioArctic's third quarter report for July - September 2024 on November 14 at 9.30 a.m. CETNovember 7, 2024 | finance.yahoo.comEisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the USNovember 1, 2024 | finance.yahoo.comBioArctic: Professor Lars Lannfelt, awarded the CTAD Lifetime Achievement Award in recognition for his pioneering work in Alzheimer's DiseaseOctober 30, 2024 | finanznachrichten.deLeqembi® revenue totaled JPY 10 billion in the third quarter 2024October 30, 2024 | finance.yahoo.comProfessor Lars Lannfelt, awarded the CTAD Lifetime Achievement Award in recognition for his pioneering work in Alzheimer's DiseaseOctober 30, 2024 | finance.yahoo.comBioAge Labs to Present at Jefferies London Healthcare ConferenceOctober 25, 2024 | finance.yahoo.comLifetime Achievement Award, lecanemab and biomarkers in focus at CTADOctober 24, 2024 | uk.finance.yahoo.comBioAge Labs intiated with a Not Rated at Goldman SachsOctober 22, 2024 | msn.comBioAge Labs initiated with an Overweight at Morgan StanleyOctober 22, 2024 | msn.comGoldman Sachs, Morgan Stanley bullish on BioAge, cite Lilly relationshipOctober 22, 2024 | msn.comOpening Day: Self-driving startup Pony.ai files for U.S. IPOOctober 20, 2024 | msn.comPrediction: These 2 Stocks Could Soar in 2025October 17, 2024 | finance.yahoo.comEisai will request reconsideration of initial decision for lecanemab in AustraliaOctober 17, 2024 | finance.yahoo.comGLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs BoomOctober 13, 2024 | fool.comInterested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO StockOctober 12, 2024 | fool.comRA Capital Management, L.P. Acquires New Stake in Bioage Labs IncOctober 8, 2024 | finance.yahoo.com2 Next-Gen Weight Loss Stocks That Are Worth Buying Right NowOctober 7, 2024 | finance.yahoo.comAn Airline, Biotechs, and More See Huge Insider BuyingOctober 6, 2024 | 247wallst.com3 Reasons to Buy BioAge Labs Stock Hand Over Fist in OctoberOctober 5, 2024 | fool.comThis IPO Biotech Stock Could Be the Next Eli LillyOctober 3, 2024 | fool.comBioage Labs Inc (BIOA)October 2, 2024 | investing.comBioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of the Concurrent Private PlacementOctober 1, 2024 | globenewswire.comBioAge Labs: Weighing The Risks And Rewards Of A Biotech RevivalSeptember 30, 2024 | seekingalpha.comBioAge, BKV shares end their first trading day flat after earlier gainsSeptember 28, 2024 | morningstar.comBioAge Labs Rings the Opening BellSeptember 26, 2024 | nasdaq.comBioAge, obesity drug developer, upsizes proposed IPOSeptember 26, 2024 | msn.comBioAge valued at $758 mln in debut as investors bet on weight-loss drug frenzySeptember 26, 2024 | reuters.comWeight-loss drug developer BioAge Labs aims to raise $198M from U.S. IPOSeptember 26, 2024 | msn.comBioAge stock rallies 29% following upsized $198M IPOSeptember 26, 2024 | msn.comBioAge Labs Announces Pricing of Upsized Initial Public OfferingSeptember 25, 2024 | globenewswire.comBioage Labs, Inc IPOs Tomorrow, Here's What You Need To KnowSeptember 25, 2024 | benzinga.comObesity drug developer BioAge Labs targets up to $640 mln valuation in upsized US IPOSeptember 25, 2024 | reuters.comObesity drug developer BioAge seeks up to $587 milllion valuation in US IPOSeptember 21, 2024 | msn.com3 Swedish Growth Companies With High Insider Ownership Up To 42% Earnings GrowthSeptember 20, 2024 | finance.yahoo.comTop Swedish Growth Stocks With High Insider Ownership In September 2024September 20, 2024 | finance.yahoo.comSwedish Growth Companies With High Insider OwnershipSeptember 19, 2024 | finance.yahoo.comWeight loss drug developer BioAge seeks up to $602M valuation in U.S. IPOSeptember 19, 2024 | msn.comObesity drug developer BioAge seeks up to $587 mln valuation in US IPOSeptember 19, 2024 | reuters.comObesity Drugmaker BioAge Seeks $158 Million in IPO, PlacementSeptember 18, 2024 | finance.yahoo.comObesity drug developer BioAge seeks up to $587 million valuation in US IPOSeptember 18, 2024 | msn.comSwedish Growth Stocks With High Insider Ownership For September 2024September 18, 2024 | uk.finance.yahoo.comSwedish Growth Companies With High Insider Ownership To WatchSeptember 18, 2024 | finance.yahoo.comTop Swedish Growth Companies With High Insider Ownership For September 2024September 17, 2024 | finance.yahoo.comTop Swedish Growth Companies With High Insider Ownership In September 2024September 16, 2024 | finance.yahoo.comU.S. IPO Weekly Recap: 2 APAC Microcaps Go Public In Short Labor Day Week As The Pipeline GrowsSeptember 7, 2024 | seekingalpha.comBioAge Labs Readies $100 Million IPO Plan For Obesity TreatmentSeptember 5, 2024 | seekingalpha.com Get (BIOA) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. BIOA Media Mentions By Week BIOA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOA News Sentiment▼0.000.46▲Average Medical News Sentiment BIOA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOA Articles This Week▼12▲BIOA Articles Average Week Get (BIOA) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACADIA Pharmaceuticals News Zai Lab News Amneal Pharmaceuticals News Janux Therapeutics News Protagonist Therapeutics News Belite Bio News Catalyst Pharmaceuticals News Geron News Longboard Pharmaceuticals News Arrowhead Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIOA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BIOA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (BIOA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIOA Stock Alerts